Approved natural products-derived nanomedicines for disease treatment.
10.1016/S1875-5364(24)60726-0
- Author:
Xiaotong LI
1
;
Yaoyao LAI
1
;
Guanghan WAN
1
;
Jiahui ZOU
1
;
Wei HE
2
;
Pei YANG
3
,
4
Author Information
1. School of Pharmacy, China Pharmaceutical University, Nanjing 2111198, China.
2. School of Pharmacy, China Pharmaceutical University, Nanjing 2111198, China. Electronic address: weihe@cpu.edu.cn.
3. School of Science, China Pharmaceutical University, Nanjing 2111198, China. Electronic address: pharmyp@
4. com.
- Publication Type:Review
- Keywords:
Diagnosis;
Disease treatment;
Drug carriers;
Nanomedicine;
Natural properties;
Safety
- MeSH:
Animals;
Humans;
Biological Products/chemistry*;
Drug Carriers/chemistry*;
Drug Delivery Systems;
Nanomedicine/methods*
- From:
Chinese Journal of Natural Medicines (English Ed.)
2024;22(12):1100-1116
- CountryChina
- Language:English
-
Abstract:
In recent years, there has been an increasing emphasis on exploring innovative drug delivery approaches due to the limitations of conventional therapeutic strategies, such as inadequate drug targeting, insufficient therapeutic efficacy, and significant adverse effects. Nanomedicines have emerged as a promising solution with notable advantages, including extended drug circulation, targeted delivery, and improved bioavailability, potentially enhancing the clinical treatment of various diseases. Natural products/materials-derived nanomedicines, characterized by their natural therapeutic efficacy, superior biocompatibility, and safety profile, play a crucial role in nanomedicine-based treatments. This review provides a comprehensive overview of currently approved natural products-derived nanomedicines, emphasizing the essential properties of natural products-derived drug carriers, their applications in clinical diagnosis and treatment, and the current therapeutic potential and challenges. The aim is to offer guidance for the application and further development of these innovative therapeutic approaches.
